Table 2.
|
Time intervals |
||||||||
---|---|---|---|---|---|---|---|---|---|
Patient | 0 hours | 0.5 hours | 1 hour | 1.5 hours | 2 hours | 2.5 hours | 3 hours | 3.5 hours | 4 hours |
Prochloperazine | |||||||||
1 | 3 | 1 | 0 | 0 | 0 | 1 | 2 | 2 | 1 |
2 | 3 | 3 | 3 | 2 | 1 | 0 | 0 | 0 | 0 |
3 | 4 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 2 |
4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
5 | 5 | 5 | 5 | 4 | 3 | 3 | 3 | 3 | 2 |
6 | 8 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
7 | 4 | 2 | 2 | 2 | 1 | 2 | 1 | 1 | |
8 | 5 | 6 | 4 | 3 | 3 | 2 | 3 | 2 | 3 |
9 | 6 | 5 | 4 | 5 | 5 | 5 | 4 | 4 | 4 |
10 | 5 | 4 | 2 | 1 | 1 | 0 | 0 | 1 | 0 |
11 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
12 | 7 | 4 | 2 | 2 | 2 | 7 | 4 | ||
13 | 10 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
14 | 5 | 2 | 1 | 0 | 0 | 0 | 9 | 5 | 2 |
15 | 2 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
16 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | |
17 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
18 | 5 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | |
19 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
20 | 4 | 3 | 3 | 3 | 3 | 3 | 2 | 1 | 1 |
21 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 10 |
22 | 4 | 3 | 3 | 1 | 1 | 0 | 1 | 1 | 0 |
23 | 3 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
24 | 4 | 3 | 1 | 1 | 1 | 1 | 2 | 3 | 3 |
5-HT3 receptor antagonist | |||||||||
25 | 4 | 3 | 2 | 3 | 3 | 3 | 4 | 2 | 1 |
26 | 7 | 2 | 3 | 4 | |||||
27 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Blank sites represent times that patients did not report data.